NEWS
AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment
AMIVAS Ireland Ltd (AMIVAS), a biopharmaceutical company focused on developing, commercialising, manufacturing and distributing artesunate for the treatment of severe malaria, today announced the launch of Artesunate AMIVAS® in Europe and the U.K.
AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK
AMIVAS Ireland Ltd. Receives Authorisation from the Medicines & Healthcare Products Regulatory Agency (MHRA) to Market Artesunate Amivas® (artesunate) in the UK for Initial Treatment of Severe Malaria